P2.05-058 Blood biomarkers of inflammation, tumor burden and proliferation predict radiotherapy response and toxicity in lung cancer.
Authors
Salem, AhmedMistry, H
Backen, Alison C
Hodgson, Clare
Koh, Pek K
Dean, Emma J
Priest, Lynsey
Dive, Caroline
Renehan, Andrew G
Faivre-Finn, Corinne
Blackhall, Fiona H
Affiliation
Division of Molecular & Clinical Cancer Sciences, University of Manchester, Manchester, United KingdomIssue Date
2017-01
Metadata
Show full item recordCitation
P2.05-058 Blood biomarkers of inflammation, tumor burden and proliferation predict radiotherapy response and toxicity in lung cancer. 2017, 12 (1):S1067 Journal of Thoracic OncologyJournal
Journal of Thoracic OncologyDOI
10.1016/j.jtho.2016.11.1493Additional Links
http://linkinghub.elsevier.com/retrieve/pii/S1556086416327344Type
Meetings and ProceedingsLanguage
enISSN
15560864ae974a485f413a2113503eed53cd6c53
10.1016/j.jtho.2016.11.1493